Results 201 to 210 of about 6,820 (243)

Residual Neuromuscular Blockade.

AANA journal, 2016
This article provides an update on residual neuromuscular blockade for nurse anesthetists. The neuromuscular junction, pharmacology for producing and reversing neuromuscular blockade, monitoring sites and methods, and patient implications relating to incomplete reversal of neuromuscular blockade are reviewed.
Anna L, Plummer-Roberts, Christina, Trost, Shawn, Collins, Ian, Hewer   +3 more
openaire   +4 more sources

Residual Neuromuscular Blockade in the Critical Care Setting

AACN Advanced Critical Care, 2018
Residual neuromuscular blockade is a widespread challenge for providers in the acute care setting that, if left unrecognized or untreated, places patients at higher risk for morbidity and mortality. The condition is estimated to occur in 26% to 88% of patients undergoing general anesthesia.
Nicole, Stawicki, Patty, Gessner
openaire   +2 more sources

Residual neuromuscular blockade and postoperative critical respiratory events: literature review

Journal of Clinical Nursing, 2014
Aims and objectivesTo investigate and synthesise published literature on the associations between residual neuromuscular blockade and critical respiratory events of postoperative adult patients in the postanaesthesia care unit.BackgroundResidual neuromuscular blockade continues to be common among patients transferred to the postanaesthesia care unit ...
Panagiotis Kiekkas, Evangelos Konstantinou   +1 more
exaly   +4 more sources

Residual Neuromuscular Blockade and Perioperative Outcomes in the Elderly

Current Anesthesiology Reports, 2017
The aim of this review is to assess clinical investigations which have examined the use of NMBAs in the elderly, and to recommend neuromuscular management strategies that may optimize recovery in this patient population. A number of clinical studies have assessed the effect of age on NMBA duration.
Torin Shear
exaly   +2 more sources

The Effect of Residual Neuromuscular Blockade on the Speed of Reversal with Sugammadex

Anesthesia & Analgesia, 2009
Sugammadex is a modified gamma cyclodextrin compound which encapsulates rocuronium resulting in rapid reversal of residual neuromuscular blockade. We performed a post hoc analysis of data from a multicenter study designed to mimic standard clinical practice which would test the hypothesis that the presence (versus the absence) of a twitch response to ...
Paul F, White, Burcu, Tufanogullari, Ozlem, Sacan, Edward G, Pavlin, Oscar J, Viegas, Harold S, Minkowitz, M E, Hudson   +6 more
openaire   +2 more sources

Incidence of Residual Neuromuscular Blockade in a Post-Anaesthetic Care Unit [PDF]

Anaesthesia and Intensive Care, 2010
We conducted a prospective observational study to assess the incidence of residual neuromuscular blockade (RNMB) in a post-anaesthetic care unit (PACU) of a tertiary hospital. The subjects were 102 patients undergoing general anaesthesia with neuromuscular blockade (NMB).
P C, Yip, J A, Hannam, A J D, Cameron, D, Campbell   +3 more
exaly   +3 more sources

Fade of Pulmonary Function During Residual Neuromuscular Blockade

Chest, 2005
A decrement in evoked muscle force with repetitive nerve stimulation (fade) suggests impaired neuromuscular transmission. We tested the hypothesis that fade of pulmonary function, ie, a decrease in values of FVC with the second spirometric maneuver compared to the first maneuver, occurs during impaired neuromuscular transmission.Prospective study.Six ...
Matthias, Eikermann, Harald, Groeben, Barbara, Bünten, Jürgen, Peters   +3 more
openaire   +2 more sources

Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study [PDF]

British Journal of Anaesthesia, 2015
This study aimed to investigate whether reversal of rocuronium-induced neuromuscular blockade with sugammadex reduced the incidence of residual blockade and facilitated operating room discharge readiness.Adult patients undergoing abdominal surgery received rocuronium, followed by randomized allocation to sugammadex (2 or 4 mg kg(-1)) or usual care ...
B, Brueckmann, N, Sasaki, P, Grobara, M K, Li, T, Woo, J, de Bie, M, Maktabi, J, Lee, J, Kwo, R, Pino, A S, Sabouri, F, McGovern, A K, Staehr-Rye, M, Eikermann   +13 more
exaly   +3 more sources

Postoperative Residual Neuromuscular Blockade Is Associated With Impaired Clinical Recovery

Survey of Anesthesiology, 2013
In this investigation, we sought to determine the association between objective evidence of residual neuromuscular blockade (train-of-four [TOF] ratio
Glenn S, Murphy, Joseph W, Szokol, Michael J, Avram, Steven B, Greenberg, Torin, Shear, Jeffery S, Vender, Jayla, Gray, Elizabeth, Landry   +7 more
openaire   +2 more sources

[Residual neuromuscular blockade].

Annales francaises d'anesthesie et de reanimation, 2005
Despite the availability of modern neuromuscular blocking agents with short or intermediate duration of action, incidence of residual neuromuscular blockade remains very high. Evidences have been recently provided that residual curarization must be defined as a train-of-four ratio below 0.9 at the thumb adductor during the recovery period after ...
M, Beaussier, M A, Boughaba
openaire   +1 more source